Huntington's disease

Research output: Contribution to journalArticle

Abstract

Huntington's disease (HD) is an autosomal dominant progressive neuropsychiatric disorder, characterized by abnormalities of movement, emotion and cognition. The most important pathological feature is selective neuronal loss, primarily in the striatum and cerebral cortex. HD is caused by the expansion of a CAG trinucleotide repeat in the gene encoding huntingtin. The expanded repeat encodes an abnormally long polyglutamine tract, and many lines of evidence now strongly suggest that this mutation is neurotoxic. In this review, we first detail the clinical, genetic and pathological features of HD. We then describe how clues from neurotoxicological, biochemical, cell, transgenic mouse, and invertebrate models of HD lead to a multifactored model of HD pathogenesis. We conclude by discussing how the model of HD serves as a guide to the development of rational therapeutics for this devastating disease.

Original languageEnglish (US)
Pages (from-to)142-152
Number of pages11
JournalClinical Neuroscience Research
Volume1
Issue number1-2
StatePublished - 2001

Fingerprint

Huntington Disease
Trinucleotide Repeats
Invertebrates
Cerebral Cortex
Cognition
Transgenic Mice
Emotions
Mutation
Genes

Keywords

  • Glutamine
  • Huntington
  • Movement
  • Neurodegeneration
  • Psychiatric
  • Trinucleotide repeat

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neurology
  • Neuropsychology and Physiological Psychology

Cite this

Huntington's disease. / Ross, Christopher A; Margolis, Russell Louis.

In: Clinical Neuroscience Research, Vol. 1, No. 1-2, 2001, p. 142-152.

Research output: Contribution to journalArticle

@article{def185d3c5b54e828c750cbcbbbe0f7b,
title = "Huntington's disease",
abstract = "Huntington's disease (HD) is an autosomal dominant progressive neuropsychiatric disorder, characterized by abnormalities of movement, emotion and cognition. The most important pathological feature is selective neuronal loss, primarily in the striatum and cerebral cortex. HD is caused by the expansion of a CAG trinucleotide repeat in the gene encoding huntingtin. The expanded repeat encodes an abnormally long polyglutamine tract, and many lines of evidence now strongly suggest that this mutation is neurotoxic. In this review, we first detail the clinical, genetic and pathological features of HD. We then describe how clues from neurotoxicological, biochemical, cell, transgenic mouse, and invertebrate models of HD lead to a multifactored model of HD pathogenesis. We conclude by discussing how the model of HD serves as a guide to the development of rational therapeutics for this devastating disease.",
keywords = "Glutamine, Huntington, Movement, Neurodegeneration, Psychiatric, Trinucleotide repeat",
author = "Ross, {Christopher A} and Margolis, {Russell Louis}",
year = "2001",
language = "English (US)",
volume = "1",
pages = "142--152",
journal = "Clinical Neuroscience Research",
issn = "1566-2772",
publisher = "Elsevier BV",
number = "1-2",

}

TY - JOUR

T1 - Huntington's disease

AU - Ross, Christopher A

AU - Margolis, Russell Louis

PY - 2001

Y1 - 2001

N2 - Huntington's disease (HD) is an autosomal dominant progressive neuropsychiatric disorder, characterized by abnormalities of movement, emotion and cognition. The most important pathological feature is selective neuronal loss, primarily in the striatum and cerebral cortex. HD is caused by the expansion of a CAG trinucleotide repeat in the gene encoding huntingtin. The expanded repeat encodes an abnormally long polyglutamine tract, and many lines of evidence now strongly suggest that this mutation is neurotoxic. In this review, we first detail the clinical, genetic and pathological features of HD. We then describe how clues from neurotoxicological, biochemical, cell, transgenic mouse, and invertebrate models of HD lead to a multifactored model of HD pathogenesis. We conclude by discussing how the model of HD serves as a guide to the development of rational therapeutics for this devastating disease.

AB - Huntington's disease (HD) is an autosomal dominant progressive neuropsychiatric disorder, characterized by abnormalities of movement, emotion and cognition. The most important pathological feature is selective neuronal loss, primarily in the striatum and cerebral cortex. HD is caused by the expansion of a CAG trinucleotide repeat in the gene encoding huntingtin. The expanded repeat encodes an abnormally long polyglutamine tract, and many lines of evidence now strongly suggest that this mutation is neurotoxic. In this review, we first detail the clinical, genetic and pathological features of HD. We then describe how clues from neurotoxicological, biochemical, cell, transgenic mouse, and invertebrate models of HD lead to a multifactored model of HD pathogenesis. We conclude by discussing how the model of HD serves as a guide to the development of rational therapeutics for this devastating disease.

KW - Glutamine

KW - Huntington

KW - Movement

KW - Neurodegeneration

KW - Psychiatric

KW - Trinucleotide repeat

UR - http://www.scopus.com/inward/record.url?scp=0001337742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0001337742&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 142

EP - 152

JO - Clinical Neuroscience Research

JF - Clinical Neuroscience Research

SN - 1566-2772

IS - 1-2

ER -